Public Joint-Stock Company "Pharmsynthez" (LIFE.ME)
RUB 4.51
(10.15%)
RUB 4.51
(10.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -139.88 Million RUB | 54.88% |
| 2021 | -647 Million RUB | 12.05% |
| 2020 | -199.24 Million RUB | 49.86% |
| 2019 | -1.68 Billion RUB | -2121.63% |
| 2018 | -213.49 Million RUB | 101.31% |
| 2017 | -1 Billion RUB | -419.31% |
| 2016 | -613.45 Million RUB | -2.05% |
| 2015 | -364.41 Million RUB | -247.62% |
| 2014 | -158.53 Million RUB | -17.52% |
| 2013 | -119.1 Million RUB | 0.0% |
| 2011 | 31 Million RUB | 9.5% |
| 2010 | 28 Million RUB | 205.72% |
| 2009 | 9.26 Million RUB | 27.79% |
| 2008 | 7.24 Million RUB | -70.87% |
| 2007 | 24.87 Million RUB | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -19.2 Million RUB | 0.0% |
| 2023 Q1 | -19.2 Million RUB | 35.27% |
| 2022 Q4 | -29.66 Million RUB | 0.0% |
| 2022 Q1 | -21.33 Million RUB | 78.45% |
| 2022 FY | - RUB | 54.88% |
| 2022 Q2 | -53.68 Million RUB | -151.6% |
| 2022 Q3 | -29.66 Million RUB | 44.75% |
| 2021 FY | - RUB | 12.05% |
| 2021 Q2 | -196.97 Million RUB | -55.63% |
| 2021 Q3 | 28.39 Million RUB | 114.42% |
| 2021 Q4 | -99.01 Million RUB | -448.72% |
| 2021 Q1 | -126.56 Million RUB | -129.22% |
| 2020 Q4 | -55.21 Million RUB | -1263.38% |
| 2020 Q1 | -47.43 Million RUB | 32.96% |
| 2020 FY | - RUB | 49.86% |
| 2020 Q2 | -43.44 Million RUB | 8.4% |
| 2020 Q3 | -4.05 Million RUB | 90.68% |
| 2019 Q1 | -16.03 Million RUB | -136.91% |
| 2019 Q3 | -79.85 Million RUB | -34.86% |
| 2019 Q4 | -70.74 Million RUB | 11.41% |
| 2019 FY | - RUB | -2121.63% |
| 2019 Q2 | -59.21 Million RUB | -269.22% |
| 2018 Q3 | 43.44 Million RUB | 139.62% |
| 2018 Q2 | -109.65 Million RUB | 0.0% |
| 2018 Q1 | -109.65 Million RUB | 58.28% |
| 2018 FY | - RUB | 101.31% |
| 2018 Q4 | 43.44 Million RUB | 0.0% |
| 2017 Q3 | -262.86 Million RUB | -19.8% |
| 2017 FY | - RUB | -419.31% |
| 2017 Q1 | -219.42 Million RUB | 65.66% |
| 2017 Q4 | -262.86 Million RUB | 0.0% |
| 2017 Q2 | -219.42 Million RUB | 0.0% |
| 2016 Q4 | -639 Million RUB | 0.0% |
| 2016 Q3 | -639 Million RUB | -267.02% |
| 2016 FY | - RUB | -2.05% |
| 2016 Q1 | 382.58 Million RUB | 402.48% |
| 2016 Q2 | 382.58 Million RUB | 0.0% |
| 2015 Q3 | -126.48 Million RUB | 4.45% |
| 2015 FY | - RUB | -247.62% |
| 2015 Q1 | -132.37 Million RUB | -48.02% |
| 2015 Q4 | -126.48 Million RUB | 0.0% |
| 2015 Q2 | -132.37 Million RUB | 0.0% |
| 2014 Q1 | -17.25 Million RUB | 70.08% |
| 2014 Q4 | -89.43 Million RUB | 0.0% |
| 2014 FY | - RUB | -17.52% |
| 2014 Q3 | -89.43 Million RUB | -131.63% |
| 2014 Q2 | -38.61 Million RUB | -123.77% |
| 2013 Q2 | -22.73 Million RUB | -23.63% |
| 2013 Q3 | -57.68 Million RUB | -153.72% |
| 2013 Q4 | -57.68 Million RUB | 0.0% |
| 2013 Q1 | -18.38 Million RUB | 0.0% |
| 2013 FY | - RUB | 0.0% |
| 2011 FY | - RUB | 9.5% |
| 2010 FY | - RUB | 205.72% |
| 2009 FY | - RUB | 27.79% |
| 2008 FY | - RUB | -70.87% |
| 2007 FY | - RUB | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|